Small Minneapolis businesses hit hard by ICE crackdown, while corporations stay silent
Small Minneapolis businesses hit hard by ICE crackdown, while corporations stay silent
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Which part of the AI trade is more likely to better serve investors?
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Small Minneapolis businesses hit hard by ICE crackdown, while corporations stay silent
In the meantime, here's how to claim the $20 credit Verizon is offering in response to this week's service disruption.
Micron stock rises 5% amid memory sector strength and insider buying
Morgan Stanley bullish on space stock: Launch cadence, policy support lift outlook
Dealmakers see more retail mergers and IPOs in 2026 after tariffs sidelined M&A last year
Boot up your laptop and hit "Post" because Yahoo Finance is taking a look at how social media stocks are faring in 2026. Shares of Facebook and Instagram p...
Stubborn inflation, high tariffs and plunging job creation didn't do much to slow the economy in 2025. Now the stage is set for even stronger growth.
A mix of soaring metals prices, geopolitical risks and threats to the Federal Reserve's independence is raising the possibility that inflation may push hig...
Jefferies' Christopher Wood eliminated a 10% Bitcoin allocation in favor of gold, warning that quantum computing advances could undermine cryptographic sec...
Renewed spot Ethereum ETF inflows topped $474 million this week while network metrics smashed records, positioning ETH for a rally to $4,500 in the coming...
Morgan Stanley lifts ASML stock target by 40% on expectations for a stronger 2027
Some drugmakers quietly concerned about legal risk with speedy FDA review program